文献速递浆细胞疾病贫血与红细胞疾病

轻链管型肾病的肾脏结局预测因素:多中心回顾性研究

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.
PubMed 文献 · Blood · 2020-01-01

该多中心回顾性研究纳入178例经活检证实的轻链管型肾病(LCCN)患者,评估临床与病理指标对肾脏及患者结局的预测价值。中位随访22个月,平均eGFR从诊断时13±11升至43±30 mL/min/1.73 m2。皮质管型数量与IFTA程度独立预测随访期eGFR,而eGFR与总生存相关且独立于血液学缓解。

要点

  • 皮质管型密度和IFTA程度独立预测LCCN肾脏缓解质量
  • 随访期eGFR与总生存相关,独立于血液学缓解
  • 年龄、β2微球蛋白和最佳血液学缓解也独立关联随访eGFR

核心结论

  • LCCN中管型形成范围和IFTA可预测肾脏缓解质量,而肾脏缓解质量与总生存相关。

研究设计与样本

  • 欧洲和北美10个中心的多中心回顾性研究,纳入178例经活检证实的LCCN患者。
  • 回顾性分析临床表现、化疗方案、血液学缓解及肾脏和患者结局,并进行详细病理 review 评估管型形成范围。

主要发现

  • 患者诊断时平均eGFR为13±11 mL/min/1.73 m2,82%为3期急性肾损伤。
  • 皮质平均管型数为3.2/mm2;常见小管间质病变包括急性小管损伤94%、小管炎82%、小管破裂62%、巨细胞反应60%、皮质和髓质炎症分别为95%和75%。
  • 髓质炎症、巨细胞反应和管型形成范围与LCCN诊断时eGFR值相关。
  • 中位随访22个月,平均eGFR增至43±30 mL/min/1.73 m2。
  • 年龄、β2微球蛋白、最佳血液学缓解、每平方毫米皮质管型数和IFTA程度独立关联随访期较高eGFR。

关键数值与推荐

  • 随访期eGFR与总生存相关,且独立于血液学缓解。

临床怎么用

  • 肾活检病理评估管型范围和IFTA有助于预测LCCN肾脏缓解质量。
  • 随访期eGFR可作为与总生存相关的监测指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Light chain cast nephropathy (LCCN) in multiple myeloma often leads to severe and poorly reversible acute kidney injury. Severe renal impairment influences the allocation of chemotherapy and its tolerability; it also affects patient survival. Whether renal biopsy findings add to the clinical assessment in predicting renal and patient outcomes in LCCN is uncertain. We retrospectively reviewed clinical presentation, chemotherapy regimens, hematologic response, and renal and patient outcomes in 178 patients with biopsy-proven LCCN from 10 centers in Europe and North America. A detailed pathology review, including assessment of the extent of cast formation, was performed to study correlations with initial presentation and outcomes. Patients presented with a mean estimated glomerular filtration rate (eGFR) of 13 ± 11 mL/min/1.73 m2, and 82% had stage 3 acute kidney injury. The mean number of casts was 3.2/mm2 in the cortex. Tubulointerstitial lesions were frequent: acute tubular injury (94%), tubulitis (82%), tubular rupture (62%), giant cell reaction (60%), and cortical and medullary inflammation (95% and 75%, respectively). Medullary inflammation, giant cell reaction, and the extent of cast formation correlated with eGFR value at LCCN diagnosis. During a median follow-up of 22 months, mean eGFR increased to 43 ± 30 mL/min/1.73 m2. Age, β2-microglobulin, best hematologic response, number of cortical casts per square millimeter, and degree of interstitial fibrosis/tubular atrophy (IFTA) were independently associated with a higher eGFR during follow-up. This eGFR value correlated with overall survival, independently of the hematologic response. This study shows that extent of cast formation and IFTA in LCCN predicts the quality of renal response, which, in turn, is associated with overall survival.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Royal V, Leung N, Troyanov S, et al. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. Blood. 2020. PMID: 32160635. doi:10.1182/blood.2019003807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。